Annual EBIT
-$21.16 M
-$3.02 M-16.66%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual earnings before interest & taxes is -$21.16 million, with the most recent change of -$3.02 million (-16.66%) on December 31, 2023.
- During the last 3 years, COCP annual EBIT has fallen by -$11.52 million (-119.49%).
- COCP annual EBIT is now -90911.16% below its all-time high of $23.30 thousand, reached on December 31, 2010.
Performance
COCP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.04 M
+$406.00 K+7.45%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly earnings before interest & taxes is -$5.04 million, with the most recent change of +$406.00 thousand (+7.45%) on September 30, 2024.
- Over the past year, COCP quarterly EBIT has increased by +$1.00 million (+16.56%).
- COCP quarterly EBIT is now -269.37% below its all-time high of $2.98 million, reached on March 31, 2019.
Performance
COCP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$20.31 M
+$1.00 M+4.70%
September 30, 2024
Summary
- As of February 8, 2025, COCP TTM earnings before interest & taxes is -$20.31 million, with the most recent change of +$1.00 million (+4.70%) on September 30, 2024.
- Over the past year, COCP TTM EBIT has dropped by -$319.00 thousand (-1.60%).
- COCP TTM EBIT is now -4451.76% below its all-time high of $466.80 thousand, reached on September 30, 2010.
Performance
COCP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
COCP EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.7% | +16.6% | -1.6% |
| 3 y3 years | -119.5% | -12.0% | -12.0% |
| 5 y5 years | +66.2% | -12.0% | -12.0% |
COCP EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -49.2% | at low | -36.8% | +16.6% | -43.3% | +4.7% |
| 5 y | 5-year | -119.5% | +56.1% | -238.2% | +89.5% | -110.7% | +63.7% |
| alltime | all time | <-9999.0% | +80.0% | -269.4% | +94.8% | -4451.8% | +81.2% |
Cocrystal Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.04 M(-7.5%) | -$20.31 M(-4.7%) |
| Jun 2024 | - | -$5.45 M(+31.0%) | -$21.32 M(+5.5%) |
| Mar 2024 | - | -$4.16 M(-26.6%) | -$20.21 M(-4.5%) |
| Dec 2023 | -$21.16 M(+16.7%) | -$5.67 M(-6.2%) | -$21.16 M(+5.8%) |
| Sep 2023 | - | -$6.04 M(+39.3%) | -$20.00 M(+1.8%) |
| Jun 2023 | - | -$4.34 M(-15.1%) | -$19.65 M(+3.2%) |
| Mar 2023 | - | -$5.11 M(+13.5%) | -$19.04 M(+5.0%) |
| Dec 2022 | -$18.14 M(+27.9%) | -$4.50 M(-20.9%) | -$18.14 M(+4.7%) |
| Sep 2022 | - | -$5.69 M(+52.4%) | -$17.32 M(+11.3%) |
| Jun 2022 | - | -$3.74 M(-11.2%) | -$15.57 M(-0.5%) |
| Mar 2022 | - | -$4.21 M(+14.2%) | -$15.65 M(+10.4%) |
| Dec 2021 | -$14.18 M(+47.1%) | -$3.69 M(-6.5%) | -$14.18 M(+18.3%) |
| Sep 2021 | - | -$3.94 M(+3.2%) | -$11.99 M(+11.9%) |
| Jun 2021 | - | -$3.82 M(+39.5%) | -$10.71 M(+3.1%) |
| Mar 2021 | - | -$2.74 M(+83.6%) | -$10.39 M(+7.8%) |
| Dec 2020 | -$9.64 M(-80.0%) | -$1.49 M(-44.1%) | -$9.64 M(-82.8%) |
| Sep 2020 | - | -$2.67 M(-23.6%) | -$55.99 M(+1.6%) |
| Jun 2020 | - | -$3.49 M(+75.7%) | -$55.10 M(+3.7%) |
| Mar 2020 | - | -$1.99 M(-95.8%) | -$53.12 M(+10.3%) |
| Dec 2019 | -$48.15 M(-23.0%) | -$47.84 M(+2595.3%) | -$48.15 M(-15.1%) |
| Sep 2019 | - | -$1.77 M(+17.5%) | -$56.71 M(-1.0%) |
| Jun 2019 | - | -$1.51 M(-150.7%) | -$57.29 M(-0.6%) |
| Mar 2019 | - | $2.98 M(-105.3%) | -$57.65 M(-7.9%) |
| Dec 2018 | -$62.57 M(+657.3%) | -$56.41 M(+2299.2%) | -$62.57 M(+682.5%) |
| Sep 2018 | - | -$2.35 M(+25.5%) | -$8.00 M(+3.1%) |
| Jun 2018 | - | -$1.87 M(-3.5%) | -$7.75 M(+9.5%) |
| Mar 2018 | - | -$1.94 M(+5.9%) | -$7.08 M(-7.9%) |
| Dec 2017 | -$8.26 M(-92.2%) | -$1.83 M(-13.2%) | -$7.69 M(-92.5%) |
| Sep 2017 | - | -$2.11 M(+75.8%) | -$102.56 M(+0.2%) |
| Jun 2017 | - | -$1.20 M(-52.9%) | -$102.33 M(-2.9%) |
| Mar 2017 | - | -$2.55 M(-97.4%) | -$105.33 M(-2.6%) |
| Dec 2016 | -$105.82 M | -$96.70 M(+5040.8%) | -$108.12 M(+93.8%) |
| Sep 2016 | - | -$1.88 M(-55.3%) | -$55.79 M(-3.0%) |
| Jun 2016 | - | -$4.20 M(-21.2%) | -$57.50 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$5.33 M(-88.0%) | -$57.11 M(+5.9%) |
| Dec 2015 | -$53.95 M(+830.3%) | -$44.37 M(+1136.0%) | -$53.95 M(+380.2%) |
| Sep 2015 | - | -$3.59 M(-5.9%) | -$11.23 M(+26.7%) |
| Jun 2015 | - | -$3.82 M(+76.1%) | -$8.86 M(+37.8%) |
| Mar 2015 | - | -$2.17 M(+30.6%) | -$6.43 M(+11.0%) |
| Dec 2014 | -$5.80 M(+42.1%) | -$1.66 M(+36.2%) | -$5.80 M(+13.2%) |
| Sep 2014 | - | -$1.22 M(-12.1%) | -$5.12 M(+4.4%) |
| Jun 2014 | - | -$1.39 M(-9.5%) | -$4.91 M(+7.8%) |
| Mar 2014 | - | -$1.53 M(+55.4%) | -$4.55 M(+11.6%) |
| Dec 2013 | -$4.08 M(+70.0%) | -$986.00 K(-1.9%) | -$4.08 M(-30.9%) |
| Sep 2013 | - | -$1.00 M(-2.5%) | -$5.90 M(+30.1%) |
| Jun 2013 | - | -$1.03 M(-2.6%) | -$4.54 M(+41.5%) |
| Mar 2013 | - | -$1.06 M(-62.3%) | -$3.20 M(+38.1%) |
| Dec 2012 | -$2.40 M(-43.0%) | -$2.81 M(-878.9%) | -$2.32 M(+275.4%) |
| Sep 2012 | - | $360.40 K(+20.0%) | -$617.90 K(-80.7%) |
| Jun 2012 | - | $300.40 K(-273.4%) | -$3.19 M(-19.2%) |
| Mar 2012 | - | -$173.20 K(-84.3%) | -$3.95 M(+7.3%) |
| Dec 2011 | -$4.21 M(<-9900.0%) | -$1.11 M(-50.1%) | -$3.69 M(+12.5%) |
| Sep 2011 | - | -$2.22 M(+382.1%) | -$3.27 M(+325.3%) |
| Jun 2011 | - | -$459.70 K(-577.4%) | -$769.90 K(+556.9%) |
| Mar 2011 | - | $96.30 K(-113.9%) | -$117.20 K(-46.0%) |
| Dec 2010 | $23.30 K(-154.4%) | -$694.80 K(-341.0%) | -$217.10 K(-146.5%) |
| Sep 2010 | - | $288.30 K(+49.4%) | $466.80 K(+172.0%) |
| Jun 2010 | - | $193.00 K(-5461.1%) | $171.60 K(-693.8%) |
| Mar 2010 | - | -$3600.00(-67.0%) | -$28.90 K(-32.5%) |
| Dec 2009 | -$42.80 K(-23.4%) | -$10.90 K(+58.0%) | -$42.80 K(+4.6%) |
| Sep 2009 | - | -$6900.00(-8.0%) | -$40.90 K(-5.5%) |
| Jun 2009 | - | -$7500.00(-57.1%) | -$43.30 K(-15.4%) |
| Mar 2009 | - | -$17.50 K(+94.4%) | -$51.20 K(-8.4%) |
| Dec 2008 | -$55.90 K(-9.1%) | -$9000.00(-3.2%) | -$55.90 K(-22.0%) |
| Sep 2008 | - | -$9300.00(-39.6%) | -$71.70 K(-22.2%) |
| Jun 2008 | - | -$15.40 K(-30.6%) | -$92.20 K(+20.1%) |
| Mar 2008 | - | -$22.20 K(-10.5%) | -$76.80 K(+40.7%) |
| Dec 2007 | -$61.50 K | -$24.80 K(-16.8%) | -$54.60 K(+83.2%) |
| Sep 2007 | - | -$29.80 K | -$29.80 K |
FAQ
- What is Cocrystal Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cocrystal Pharma?
- What is Cocrystal Pharma annual EBIT year-on-year change?
- What is Cocrystal Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly EBIT year-on-year change?
- What is Cocrystal Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cocrystal Pharma?
- What is Cocrystal Pharma TTM EBIT year-on-year change?
What is Cocrystal Pharma annual earnings before interest & taxes?
The current annual EBIT of COCP is -$21.16 M
What is the all time high annual EBIT for Cocrystal Pharma?
Cocrystal Pharma all-time high annual earnings before interest & taxes is $23.30 K
What is Cocrystal Pharma annual EBIT year-on-year change?
Over the past year, COCP annual earnings before interest & taxes has changed by -$3.02 M (-16.66%)
What is Cocrystal Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of COCP is -$5.04 M
What is the all time high quarterly EBIT for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly earnings before interest & taxes is $2.98 M
What is Cocrystal Pharma quarterly EBIT year-on-year change?
Over the past year, COCP quarterly earnings before interest & taxes has changed by +$1.00 M (+16.56%)
What is Cocrystal Pharma TTM earnings before interest & taxes?
The current TTM EBIT of COCP is -$20.31 M
What is the all time high TTM EBIT for Cocrystal Pharma?
Cocrystal Pharma all-time high TTM earnings before interest & taxes is $466.80 K
What is Cocrystal Pharma TTM EBIT year-on-year change?
Over the past year, COCP TTM earnings before interest & taxes has changed by -$319.00 K (-1.60%)